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Introduction: It is known that aging results in an increased risk for cardiovascular disease 
(CVD) related events. Age-related CVD events are associated with arterial stiffening 
independent of traditional risk factors. Extra-media thickness (EMT) is a novel structural 
component of the carotid artery composed of perivascular adipose tissue (PVAT), arterial 
adventitia, and the interstitial wall that may be associated with age-related arterial 
stiffness. However, it is unknown what affect dietary interventions have on EMT and 
arterial stiffness. Purpose: The purpose of this study was to determine if an 8-week 
COCOZEN intervention decreases age-related EMT and arterial stiffness. Methods: 
Sixteen participants with a mean age of 54.81 ± 7.0 years old were randomly assigned to 
either COCOZEN or the Placebo for 8 weeks. Carotid artery stiffness, and carotid and 
brachial blood pressure were acquired before and after the intervention. A two-way 
repeated-measures analysis of variance (ANOVA) was used to analyze changes over 
time, an unpaired one-tailed t-test was utilized to determine percent (%) change on blood 
pressure (BP), between groups, and a correlation at baseline was used to determine 
associations between EMT and arterial stiffness. Results: Carotid systolic blood pressure 
(CSBP; mmHg) and brachial systolic blood pressure (BSBP; mmHg) were decreased in 
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the COCOZEN group demonstrated, with a 6.57% and 6.64% decrease (p=0.039, 0.022), 
respectively. There were no differences between groups for EMT or carotid compliance 
(p≥0.05). Carotid distensibility (10-3/kPa) and β-stiffness (AU) decreased 0.005 ± 0.002 to 
0.003 ± 0.002 and increased 3.13 ± 0.40 to 3.40 ± 0.34, respectively, in the placebo group 
(p≤0.05). Conclusion: COCOZEN lowered CSBP and BSBP, indicating this novel 




















Cardiovascular disease (CVD) is the leading cause of mortality worldwide (1). With 
increasing prevalence of CVD nationally and globally, the necessity to understand risk 
factors associated with this condition become clinically relevant (1,2). Aging results in an 
increased risk for CVD related events, which is associated with stiffening of the large 
elastic arteries, including the aorta and carotid artery (3,4,5,6). Arterial stiffening predicts 
CVD-related events independent of traditional risk factors and is associated with 
structural changes in the artery (2,3,4,5,6).  
With aging, arterial stiffening increases as a result of structural changes in the artery 
(4,6). The stiffening of the artery and ensuing structural changes are associated with 
inflammation within the vasculature (3,4,6). After persistent exposure to inflammation, 
specific structural components change to promote arterial stiffness (3,6,7). These 
structures include extra-media thickness (EMT), which is a composite measure that 
includes perivascular adipose tissue (PVAT), arterial adventitia and the interstitial wall of 
the carotid artery and intima-media thickness (IMT) which encompasses the tunica intima 
and media of the artery (3,6,7). Research has demonstrated that increases in EMT is 
associated with increased inflammation that contributes to stiffening (7,8,9,10,11). 
Understanding how structural components contribute to stiffness as well as other lifestyle 
choices is essential in determining the role of the EMT on and potential association with 
arterial stiffness.  
Lifestyle choices, such as diet contribute to arterial stiffness and inflammation 
(2,6). Dietary interventions have demonstrated that anti-inflammatory compounds can 
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have a positive effect on vascular health (12,13,14,15). One such compound is 
COCOZEN, which is a coconut-derived substance that has shown to have anti-
inflammatory properties (12,13). COCOZEN has previously been utilized in other cultures 
as an anti-inflammatory agent (12,13,15). However, it has limited usage in specific dietary 
interventions, and the effect of COCOZEN on EMT and arterial stiffness is unknown.   
 Therefore, the aim of this study was to determine if an 8-week COCOZEN 
intervention decreases age-related EMT and arterial stiffness, and if EMT is associated 
with arterial stiffness. We hypothesized that adherence to COCOZEN over 8-weeks would 
decrease EMT and lower arterial stiffness in middle-aged and older adults compared to 
the placebo, and that increased EMT would be associated with arterial stiffness.  
Methods 
Included within this study were 16 males and females, who were free of any known 
clinical disease. Participants were between the ages of 40-80 years old and were absent 
of diagnosed hypertension and/or anti-hypertensive medications. Participants were 
excluded if they exhibited one or more of the following: a body mass index (BMI) < 18 
kilogram/meters2 (kg/m2) or > 35 kg/m2, resting brachial blood pressure of greater than 
160/100 millimeters of mercury (mmHg),  a current smoker, known clinical disease, an 
abnormal resting 12-lead electrocardiogram (ECG), previous angina, alcohol 
dependence or abuse, more than three days of self-reported vigorous activity per week, 




This study was an 8-week, double-blind, randomized control trial. After qualifying 
for participation, participants were randomly assigned to either the COCOZEN or placebo 
group. This study included two testing sessions, the pre-test at week 0 and the post-test 
at week 8. The pre-test encompassed an informed consent and health history 
questionnaire. Participants were instructed to refrain from caffeine, alcohol, and exercise 
24 hours prior to the pre-test and were required to perform an overnight fast. The 
supplement or placebo was administered in a 28-day pill tray and given to each 
participant. Three pills at 500 milligrams (mg) each (total 1500 mg) per day were taken 
and recorded on a log sheet. Participant adherence to the supplement was 99%. The 
post-test at week 8 followed the same procedures as the pre-test.  
Anthropometrics and Blood Draw 
Baseline measurements included basic anthropometrics, encompassing height, 
weight, and body fat percentage measured with dual-energy X-ray absorptiometry 
(DEXA). Additionally, a blood draw with a full lipid profile and glucose was conducted. All 
anthropometric measures were standardized following the American College of Sports 
Medicine (ACSM) (2).  
Resting Cardiovascular Measurements  
Participants were seated approximately for five-minutes before brachial blood 
pressure was measured two times and averaged (2). Thereafter, blood pressure 
measurements at the carotid and radial pulse were performed and conducted by the same 
technician with a SphygmoCor system tonometer (7) Participants were instructed to lie 
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down in the supine position for approximately 10 minutes (7). Upon which, the pressure 
waveform measurements were obtained on the left radial pulse and left common carotid 
artery (LCCA) (7). A minimum of three measurements were taken within 4 mmHg of each 
other. The carotid pressure measurement on the LCCA was measured twice, once before 
ultrasound and then after.  
Ultrasound Measurements: EMT  
Ultrasound was performed with the participant in the supine position. A three-lead 
ECG was attached, and a longitudinal measurement of the right common carotid artery 
(RCCA) was measured (7). After capturing videos approximately 15-20 seconds long, 
EMT was measured on the near wall on the QRS-complex during diastole, 10-15 mm 
proximal of the carotid bulb in the same image (16,17,18,19). Afterward, manual 
measurement of the EMT was performed nine times over three cardiac cycles in the same 
location. 
IMT and Diameter 
IMT was measured with CV suite. The software analyzed the captured video of the 
longitudinal view of the RCCA. After the technician manually chose a specific region of 
interest on the far wall of the artery, the software auto-calculated the measurement. The 
diameter was obtained in the identical image from the same region of interest and auto-
calculates the IMT on the far wall to the IMT on the near wall during systole and diastole, 
respectively. Upon which, the average diameters were calculated over four to five cardiac 
cycles.   
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β-stiffness Index  
Carotid β-stiffness was defined as Ln (Pmax/Pmin)/[Dmax-Dmin)/Dmin] where, P 
represents pressure and D, diameter (7). The pressure component used for β-stiffness 
was performed with a SphygmoCor system tonometer on the LCCA (7). After three 
measurements of carotid blood pressure are obtained, the average systolic and diastolic 
carotid pressures were acquired and inputted into the P-max and P-min variables in the 
equation, where P-max represents the maximum systolic pressure and P-min represents 
the minimum diastolic pressure (7). The average systolic and diastolic measurements of 
the diameters were entered in the D-max and D-min portion of the equation, where D-
max represents the maximum systolic diameter and D-min represents the minimum 
diastolic diameter (7).  
Carotid Compliance and Distensibility  
Compliance and distensibility were calculated as πDmin*ΔD/2*ΔP and 
2*[(ΔD/Dmin)/ΔP], respectively (20,21). Carotid distensibility and compliance were 
calculated with the same diameters and carotid pressures utilized for β-stiffness. The ΔD 
and ΔP represents the change in diameter and pressure respectively (7,20,21).  
Statistical Analysis 
Statistical analysis was conducted through GraphPad Prism™. Baseline 
characteristics between groups were analyzed through an unpaired two-tailed t-test. 
Measures of EMT, IMT, and stiffness were analyzed through a 2-way repeated-measures 
analysis of variance (ANOVA) with an uncorrected fisher’s Least Significant Difference 
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post hoc. For %change in blood pressure an unpaired one-tailed t-test was utilized and 
at baseline a correlation was conducted to determine associations between EMT and 
arterial stiffness. Group data are presented as mean ± standard deviation, with statistical 
significance set at p≤0.05. 
Results 
There were 16 participants included within this study. At baseline, there were no 
significant differences between age, anthropometric measurements, and/or 
carotid/brachial blood pressure (p≥0.05). Descriptive characteristics between groups at 
baseline are presented in Table 1.  
Figure 1 and 2 demonstrates COCOZEN lowered both CSBP and BSBP from pre 
to post for the COCOZEN group with an 6.57% and 6.64% decrease, respectively 
(p≤0.05, both).  
COCOZEN did not change EMT or IMT over the duration of the study (Table 2); 
however, IMT increased in the placebo group (p≤0.05). Carotid compliance, distensibility 
and β-stiffness was not different for the COCOZEN group (p≥0.05). Carotid distensibility 
and β-stiffness decreased and increased, respectively for the placebo (p≤0.05, Table 3). 
Additionally, a main effect on time was demonstrated for carotid diastolic blood pressure 
(data not presented, p≤0.05). A correlation between EMT, the three measures of arterial 
stiffness (β-stiffness, carotid compliance, and carotid distensibility) was conducted, and 
results demonstrated that there was no relationship between EMT, β-stiffness, carotid 
compliance, or carotid distensibility at baseline (p≥0.05) (Table 4). 
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Baseline  Pre 
Value COCOZEN Placebo 
Age (years) 54.63 ± 8.23 55.00 ± 6.12 
Weight (kg) 79.17 ± 12.44 80.10 ± 12.17 
Height (centimeters) 171.77 ± 8.14 172.48 ± 5.96 
BMI kg/m2 26.74 ± 3.08 27.05 ± 4.84 
Brachial Systolic BP (mmHg) 117.50 ± 10.52 108.63 ± 12.36 
Brachial Diastolic BP (mmHg) 71.75 ± 7.36 67.50 ± 7.23 
Carotid Systolic BP (mmHg) 115.47 ± 17.28 105.99 ± 16.75 
Carotid Diastolic BP (mmHg) 73.50 ± 8.67 72.00 ± 7.48 
Body fat (%) 31.76 ± 8.09 40.00 ± 8.28 
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Figure 1: CSBP mean data over the pre and post between groups (left) and percent (%) 
change for both groups between the pre and post (right). *p≤0.05 vs. COCOZEN Pre for 




































Figure 2: BSBP mean data over the pre and post between groups (left) and percent (%) 
change for both groups between the pre and post (right). *p≤0.05 vs. COCOZEN Pre for 























































 COCOZEN Placebo 
 Pre Post Pre Post 
EMT (mm) 0.66 ± 0.17 0.66 ±0.17 0.66 ± 0.13 0.66 ± 0.12 
     
     
IMT (mm) 0.56 ± 0.11 0.55 ± 0.10 0.51 ± 0.07 0.55 ±0.08* 
     
 16 
Table 3: Carotid compliance, distensibility, and β-stiffness data for the pre and post 
between groups. *p≤0.05 vs. Placebo Pre. 
mm2/mmHg, millimeters squared divided by millimeters of mercury, 10-3/kPa, ten to the negative third power divided by 










 COCOZEN Placebo 
 Pre Post Pre Post 
Carotid Compliance 
(mm2/mmHg) 





0.003 ± 0.001 0.004 ± 0.001 0.005 ± 0.002 0.003 ± 0.002* 
β-Stiffness (AU) 3.33 ± 0.45 3.23 ± 0.32 3.13 ± 0.40 3.40± 0.34* 
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Table 4: EMT correlation between carotid compliance, distensibility, and β-stiffness, data 















Baseline Compared to EMT r-value P-value 




Carotid Distensibility (10-3/kPa) 
 
0.167 0.534 
β-Stiffness (AU) -0.088 0.744 
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Discussion 
The effects of COCOZEN on vascular health is unknown. Arterial stiffness, a 
measure of vascular health increases with aging, and is related to change in vascular 
structures, including EMT (3,4,6). Previous literature demonstrates efficacy for anti-
inflammatory dietary interventions to lower arterial stiffness, that may be related to 
decreases in structural components such as EMT (7,12-15). Our findings demonstrate 
that COCOZEN did not improve arterial stiffness but did decrease CSBP and BSBP in 
apparently healthy middle-aged and older adults. These findings suggest COCOZEN may 
be a novel intervention to lower blood pressure in middle-age/older adults and reduce 
future CVD risk. 
Hypertension is a risk factor for CV related events (3,6,14). Thus, the importance 
of lowering blood pressure with aging is crucial to prevent impairments of vascular health 
(3,6,14). COCOZEN is a novel nutraceutical with limited research regarding its effect on 
vascular health (12-15). Nonetheless, research in animals has demonstrated that 
COCOZEN reduced mean systolic blood pressure in hypertensive rats (15). However, 
research for COCOZEN in humans is limited (12-15). Previous research in humans has 
demonstrated other dietary interventions such as, raw beet juice, to improve vascular 
health (12-15). As such, Asgary et al, demonstrated that both raw beet juice and cooked 
beet juice improved blood pressure, endothelial function, and decreased systemic 
inflammation in hypertensive patients (14). Though inflammation was not directly 
measured in the current study, similar reductions in systolic blood pressure were 
demonstrated in the previous study with a 4.97% and 4.02% decrease for raw beet juice 
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and cooked beet juice, respectively (14). This is similar to our cohort’s reduction of 6.57% 
and 6.64% for CSBP and BSBP, respectively. Our cohort was absent of hypertension 
and/or any anti-hypertensive medications. This demonstrates that even in apparently 
healthy, non-hypertensive participants that COCOZEN has promising effects of lowering 
CV risk through reductions in carotid and peripheral systolic blood pressure.  
Contrary to our hypothesis EMT, carotid compliance, distensibility, and β-stiffness 
did not change in the COCOZEN group. EMT is a structural component of the vasculature 
(6). Traditional risk factors including hypertension affects the structural integrity of the 
artery and with aging contributes to structural remodeling (3,6,22-27). Research has 
demonstrated that arterial stiffness and remodeling in the artery occurs over the lifespan 
(27). COCOZEN has been presented as a nutraceutical that can positivity impact vascular 
health (12,13). However, it is unknown if structural remodeling can occur with a 
supplement alone over an 8-week intervention. Research has indicated that aerobic 
exercise can reverse or delay arterial stiffness and the adventitial layer of the artery (5). 
To our knowledge, no literature has demonstrated in humans that structural changes with 
an anti-inflammatory supplement alone can occur over an 8-week period. Indicating that 
possibly the time of the study was not long enough for structural changes in EMT to occur 
or signifying structural remodeling cannot occur with a supplement alone.  
Based on previous literature our rationale was that a nutraceutical supplement 
would facilitate a reduction in arterial stiffness (12-15). Research performed in Wistar rats 
(pre-treated with gentamicin) demonstrated that 20 mg/kg of bodyweight of a coconut 
flower sap supplement assisted in reduction of inflammatory markers in 16 days (12). The 
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administered dosage in the previous study averaged 3 grams (g) per day for 16 days 
versus the current study, which averaged 1.5 g per day for 56 days. (12). Indicating that 
there was no relationship between arterial stiffness and COCOZEN possibly because the 
dosage may have not been significant enough to allow for an adequate change.  
Carotid distensibility and β-stiffness decreased and increased, respectively, in the 
placebo group, while compliance did not change in either group. Factors associated with 
reductions in distensibility and increases in stiffness are increased cholesterol, body fat 
and/or dietary changes (6,7,12,13,14,17).  However, there were no statistical differences 
between either measurement over time between groups. Additionally, participants were 
instructed to remain consistent with their daily routines, including diet and exercise. 
However, diet was not controlled in this study. The placebo was a dextrin extract, which 
is a simple sugar and derivative of starch. Thus, diet with the additive effect of the sugar 
derivative placebo may have affected some of the changes exhibited. Due to the novel 
nature of this investigation, speculations surrounding COCOZEN support an anti-
inflammatory related claim (12-14). Our data support that COCOZEN supplementation 
potentially offset some of the possible changes associated with arterial stiffness (6,12,13). 
Compared to COCOZEN the placebo, did not have this effect, indicating COCOZEN 
potentially allowed for less fluctuation.  
Our findings also indicate that no associations between EMT, and arterial stiffness 
(carotid compliance, distensibility, and β-stiffness) were demonstrated at baseline. 
Previous literature has demonstrated strong associations between these measures of 
stiffness and all-cause mortality (7,20,21,28-30). Research conducted by Cai et al, 
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examined EMT and its associations to three measures of stiffness (30). Specifically, β-
stiffness, carotid distensibility, and incremental modulus of elasticity in 248, 8-year old 
children (30). Results demonstrated that EMT was positivity correlated to all three 
measures of stiffness (30). Furthermore, research performed by Skilton et al, identified 
positive correlations between EMT and CV risk factors in 175 adults (17). It was 
concluded that individuals with diabetes and dyslipidemia, demonstrated an increased 
average EMT (0.76 mm) compared to the apparently healthy control (0.69) (17). Similar 
to others, our sample had an average EMT 0.66 mm at baseline. Nonetheless, limited 
research has demonstrated no relationship between EMT and measures of stiffness (31). 
Research conducted by Cai et al, demonstrated that increased EMT in high-risk adults 
had no significant associations for risk of a CV event (31). Our sample of 16 middle-aged 
and older apparently healthy adults, however, may have been too small to detect any 
correlations (7,17,30,31). Additionally, our sample had no known clinical disease differing 
our population from other literature presented, which may have contributed to the lack of 
correlation. Lastly, if there is no association between high-risk adults, EMT, and CV 
events as was presented, then the likelihood of an association of apparently healthy 
adults, may be unlikely (31-35). 
Strengths and Limitations  
Strengths of this study included that it was a double-blinded, randomized control 
trial, which limited any potential bias. Furthermore, there were multiple time points which 
allowed for repeated measurements. Limitations of this study included a small sample 
size of 16 participants, a relatively low supplementation dosage and a short-term 
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intervention (8-weeks), which may have prevented an adequate time to allow for change 
to occur.  
Conclusion 
The main findings of this research project demonstrated that 1) COCOZEN lowers 
both CSBP and BSBP in apparently healthy middle-aged and older adults; 2) COCOZEN 
did not impact EMT or arterial stiffness compared to the placebo, and; 3) There were no 
associations between EMT and arterial stiffness. Thus, COCOZEN may lower CV risk by 
decreasing systolic blood pressure in apparently healthy, middle-aged adults.  
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Appendix: Grant Proposal  
 
Aging results in an increased risk for cardiovascular disease (CVD) related events 
(1,2,3,4). Increased age-related events are associated with arterial stiffening independent 
of traditional risk factors (2,3,4,5). Arterial stiffness is a significant risk factor for 
cardiovascular disease (CVD) (4,6). Arterial stiffness is defined as the stiffening of the 
large elastic arteries, including the aorta and carotid artery (4). Changes in blood 
pressure, smooth muscle function, and endothelial function will begin to over time affect 
the structure of the artery (1,2). These changes in structure relate to but are not limited to 
intima-media thickness (IMT), extra-media thickness (EMT) elastin, collagen, smooth 
muscle cell function, and advanced glycation end products (1,4,6,7,8). EMT is defined as 
the combination of perivascular adipose tissue (PVAT), the interstitial wall, and arterial 
adventitia of the carotid artery, and could be essential to understand as increased 
structural thickness could be related to arterial stiffness and future CVD events (4,6).  
 
A contributing factor toward arterial stiffness is inflammation (1,4). Inflammation 
contributes to a change in the function of the vasculature and generates structural 
remodeling (1,4,6,7). Suggesting that inflammation can lead to endothelial dysfunction, 
which can cause an eventual change in structure (1). Much of these functional issues 
leading to inflammation are due to lifestyle (1,9,10,11,12). PVAT, as presented by Sousa 
et al, is directly related to inflammation and oxidative stress as a result of obesity (13). 
Sousa et al, performed a study of obese and non-obese rats (13). Results demonstrated 
an increase in endothelial dysfunction and oxidative stress of the obese rats (13). 
Indicating that an increase in PVAT can increase inflammation (13). Additionally, the rats 
who performed regular aerobic exercise saw a decrease in inflammation and PVAT 
dysfunction (13).  
Moreover, Fleenor et al, demonstrated with mice who performed habitual aerobic 
exercise elicited a decrease in arterial stiffness and adventitial collagen (14). Research 
performed by Sommer et al, demonstrated increases in pressure and decreases in carotid 
compliance and distensibility from older harvested common carotid arteries (CCA) of 
deceased humans compared to the younger (15). Indicating inverse relationships 
between higher pressures and distensibility and compliance of the CCA (15). Comparable 
results were demonstrated with Schulze-Bauer et al, with stenotic femoral arteries during 
autopsy (16). The arteries that were stiffer and less compliant had a higher susceptibility 
toward stiffening (16). What this research indicates is that there is a consistent increase 
in arterial stiffness and vascular remodeling with aging (1,12-16).  
 
However, it also indicates a possible effect of aerobic or dietary interventions to 
decrease arterial stiffness and lower CVD risk. COCOZEN is a coconut-derived 
substance that has been shown to have anti-inflammatory effects (10,11,12). COCOZEN 
is utilized in other cultures as an anti-inflammatory agent (10,11,12). COCOZEN has 
limited usage in specific dietary interventions and has not been used as a supplement in 
a human intervention before and the effect on vascular health is unknown. Additionally, 
the influence of COCOZEN with age-related stiffness and EMT is unknown. Therefore, 
the focus of this study is to assess the effects of COCOZEN on arterial stiffness and EMT.  
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Question 
The research question for this study is, what effect does COCOZEN have on EMT 
and arterial stiffening in middle-aged and older adults? This will add to the scientific 
literature by eliciting information on COCOZEN’s impact on arterial stiffness and EMT. 
Thus, the purpose of this study will be to determine if adherence to 1.5 grams (g) of 
COCOZEN over 8-weeks affects arterial stiffness and EMT in middle-aged and older 
adults. We hypothesize that middle-aged and older adults adhering to an 8-week 
COCOZEN intervention, will decrease arterial stiffness and EMT. The aims of the study 
are as follows: 
1. To determine the effect of COCOZEN on arterial stiffness and EMT compared to 
a placebo in middle-aged and older adults.  
2. To determine if EMT in middle-aged and older adults is associated with arterial 
stiffness. 
Expected Outcomes 
Based on previous literature we would expect that adherence to COCOZEN over 
the course of the study will decrease arterial stiffness and EMT, and that EMT will be 
associated with arterial stiffness (13,14,15). The anti-inflammatory benefits provide a 
rationale that COCOZEN will lower arterial stiffness and EMT (10,11,12).  
Research Strategy   
Arterial stiffness is an established risk factor for CVD (4,6). Structural measures of 
the vasculature include IMT and EMT (1,17-20). Specific contributing research about 
EMT, was performed by Skilton et al who examined carotid EMT with ultrasonography in 
healthy and non-healthy individuals which were defined by the type and number of risks 
factors (21-24). This study included 175 participants ranging from 21-83 years of age (54 
diabetics, 43 with dyslipidemia, 26 with risk factors, and 52 healthy who were free of 
known disease) who participated (22). Results demonstrated an increased EMT from 
those who had dyslipidemia and diabetes compared to those who were healthy (22). 
Representing a linear relationship with EMT and CV risk factors (22). This is significant 
because increased information about EMT could elicit valuable information to predict CVD 
risk (5,6).  
Background  
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Ball State University has limited 
unpublished data from a pilot study 
investigating EMT. Some of these data are 
presented in Figure 1. Fleenor et al., studied 
21 young and old individuals (young=22-24 
years of age and old=45-67 years of age) 
performing measurements of carotid artery 
stiffness. Measurements of EMT were 
acquired as well as carotid beta stiffness 
defined as Ln (Pmax/Pmin)/[Dmax-
Dmin)/Dmin], where P stands for pressure and 
D is diameter which is located through 
ultrasound (6,7). Compliance and distensibility 
are defined as the “ease of distention” with the 
opposite leading, to a stiffer artery (7,25). 
Compliance and distensibility are calculated 
as πDmin*ΔD/2*ΔP and 2*[(ΔD/Dmin)/ΔP] 
respectively (min=diameter measured in 
diastole, d=diameter, Δ=change) (7,25,26). 
Each of these are measures of stiffness and a 
combination of function and structure (1,7,26). 
The results demonstrated that the younger 
individuals had a thinner EMT and greater carotid compliance and distensibility as, well 
as a lower beta stiffness. Demonstrating a linear relationship between EMT, stiffness, and 
age. 
Limited literature has utilized pharmaceuticals as a potential way to help limit 
inflammatory reactions within the vasculature. In other cultures, coconut-derived products 
have been utilized as a way to reduce inflammation within animal studies (10,11,12). 
Previous research of coconut-derived substance has been performed in male Wistar rats. 
Specifically, Jose et al, examined rats who were of average weight and were given a 
normal low-fat diet (10). None of the rats had any pre-existing conditions to indicate that 
they would have increased inflammation prior to the start of the study (10). Conclusions 
indicated that a coconut-derived substance subdued inflammatory markers related to 
kidney function in male Wistar rats (10). Ratheesh et al, found similar results but in human 
peripheral blood mononuclear cells indicating a potential anti-inflammatory effect which, 
could have an impact on stiffness (10,11). Thus, this provides evidence that an anti-
inflammatory supplement could affect arterial stiffness and EMT (10,11,12). However, 
there are no research findings about EMT and COCOZEN combined in a middle-aged 
and older adult population. If EMT is proven to be a useful measure in predicting CVD 
risk factors, it could impact how future vascular research is conducted (27,28).  
Innovation 
This study is innovative for three reasons. First is that EMT is a novel measurement 
(19). EMT has rarely been measured and, there is limited evidence about its association 
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towards arterial stiffness and predictive nature of CVD (6,14,21-24). Though there are 
contributing studies about other vascular structures (i.e., IMT), EMT is unknown (8,21,29). 
Thus, if this study demonstrates that EMT is correlated to arterial stiffness (5,6). EMT 
could be an important structure to study to understand further the associations to arterial 
stiffness and CVD risk (2,3,4).  
 Second, we will utilize carotid compliance, distensibility, and beta-stiffness 
calculations utilized through ultrasound and pressure measurements to see how 
COCOZEN affects arterial stiffness (6,7). There appears to be limited research about 
carotid compliance, distensibility, and beta-stiffness thus; this research could assist in 
establishing normal values for these measures of arterial stiffness (30,31). Third, 
COCOZEN as an anti-inflammatory substance has not been utilized previously in an 
intervention, thus allowing a greater understanding of its effect on vascular function and 
structure (10,11,12).  
Figure 2: Overview of the Design. 
Approach 
This study is an 8-week, double-blind, randomized control trial. The objective is to 
recruit approximately 14 participants within this study. Participants will be recruited based 
on the following inclusion criterion; between the ages of 40-80 years. Participants will be 
excluded if they exhibited one or more of the following: a body mass index (BMI) less than 
18 kilogram/meters2 (kg/m2) or greater than 35 kg/m2, resting brachial blood pressure of 
greater than 160/100 millimeters of mercury (mmHg),  a current smoker, known clinical 
disease, an abnormal resting 12-lead electrocardiogram (ECG) previous angina, alcohol 
dependence or abuse, more than three days of self-reported vigorous activity per week, 
or self-reported allergies to nuts or coconuts. 
This study includes two testing sessions (Figure 2). A pre-test at week 0 and post-
test at week 8. Participants will be randomly assigned to a group after qualifying for 
participation. The pre-test will include an informed consent and health history 
questionnaire. Participants will be instructed to refrain from caffeine, alcohol, and exercise 
24 hours prior to the pre-test and will be required to perform an overnight fast. The 
supplement or placebo will be administered in a 28-day pill tray and given to each 
participant. Three pills at 500 milligrams (mg) each (total 1500 mg) per day will be taken 
and recorded on a log sheet. Baseline measurements will include basic anthropometrics, 
such as height, weight, and body fat percentage measured with dual-energy X-ray 
absorptiometry (DEXA). Additionally, a blood draw containing a full lipid profile and 
 30 
glucose will be conducted. As well as brachial, carotid and radial pressure measurements. 
All anthropometric measures were standardized following the American College of Sports 
Medicine (ACSM) (5).  
Participants will be seated approximately for five-minutes before brachial blood 
pressure will be measured two times and averaged (5). Thereafter, carotid blood pressure 
measurements at the carotid and radial pulse will be performed and conducted by the 
same technician with a SphygmoCor system tonometer (6). Participants will be instructed 
to lie down in the supine position for approximately 10 minutes (6). Upon which, the 
pressure waveforms measurements will be obtained on the left radial pulse and left 
common carotid artery (LCCA) (6). Ultrasound will be performed in the supine position 
thereafter, the participant will be attached to a three-lead ECG, and a longitudinal 
measurement of the right common carotid artery (RCCA) will be performed (Figure 3). 
The post-test at week 8 follows the same procedures as the pre-test. To reduce variability, 
the same technician will perform the ultrasound and pressure measurements.  
Figure 3: Longitudinal view of the right common carotid artery (RCCA) using Doppler 







After all data are collected, data analysis is conducted. The specific 
standardization procedures are separated into carotid stiffness measures and EMT. 
Stiffness measures are calculated with the formulas as demonstrated above (6,7). EMT 
will be measured on the QRS complex during diastole approximately 10-15 mm proximal 
of the carotid bulb as seen on Figure 4 (6, 21-24). Afterward, manual measurement of the 
EMT will be performed nine times over three cardiac cycles. Finally, IMT, and diameter 
are measured through an automated software titled CV suite.  
Statistical analysis will be a 2-way repeated measures analysis of variance 
(ANOVA) over the pre and post, and a correlation at baseline, with statistical power and 
p-value set at p≤0.05 with an effect size of 0.8. Meaning there is a need of approximately 
14 total participants (7 per group) for this power to be achieved. With this knowledge and 
standardizations in place, the procedure enables the aims of the study to be achieved as 
a way to understand COCOZEN's effects on EMT and arterial stiffness.  
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The significance of this study design is to determine if age related arterial stiffness 
is associated with concomitant increases in EMT. It is known that arterial stiffness is a 
precursor for CVD events (1,5). Thus, the importance of understanding what directly 
causes arterial stiffness as well as contributions to stiffening of the arteries is beneficial 
as a means to extrapolate more information about how best to prevent a CV event from 
occurring. Thus, if increased EMT is correlated toward arterial stiffness this could 
implicate that preventing the thickening of EMT could prove to be beneficially to lower CV 
risk (13,21-24). Additionally, if COCOZEN impacts arterial stiffness and or EMT due to a 
reduction in inflammation this too, could provide valuable information to 
ultrasonographers to measure EMT as a way to see if there is an increased risk for an 
event due to the thickening of the EMT (1,6). Thus, if this study elicits information to 
suggest that there is a relationship between EMT and arterial stiffness, this could 
contribute valuable information about EMT correlation with CVD risk (1,2,3,4,5,6).  
Alternative Explanations  
 
Possible explanations of why there may be no effect of COCOZEN on arterial 
stiffness and EMT could be due to three reasons. The first, may be due to a low sample 
size. I will attempt to recruit 14 total participants for my research, which is a small sample. 
Thus, a possible lack of effect on the results could be due to a small sample which would 
prevent significance to be found. Second, a possible reason for no change could be due 
to the fact that EMT is not directly associated to stiffness or inflammation in middle-aged 
and older adults. Thirdly, COCOZEN as a supplement while has been tested to have 
“anti-inflammatory” properties either may not be effective, may not be enough of a dosage 
compared to previous literature, or our population may not have enough systemic 
inflammation to see a response (10,11,32). Ideally, a larger sample would be a beneficial 
way to increase the power of the study. Though the unexpected findings were not as 
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hypothesized this could demonstrate different significance in other areas that were 
measured but were not the main outcomes of the study. 
 
Personal Narrative  
Since 2014, I studied exercise science and learned specific strategies to apply 
basic principles and techniques to research methods. During my undergraduate work at 
Taylor University, I completed a research methods class that included the development 
and implementation of a research study. This study examined the effect of 
supplementation on resistance training. More specifically, the study examined the effect 
of a pre-workout supplement on moderately trained males on 1-rep max in the bench 
press and box squat. The objectives of the class assignment were 1) to gain an 
understanding of the research process by developing and conducting a research study, 
and 2) to implement the methods and tools of research. The study provided the 
opportunity to experience the complete research process. For example, I developed an 
Institutional Review Board (IRB) proposal. Thus, my research experience started before 
graduate school. Additionally, I practiced and became proficient at the techniques 
involved in this COCOZEN study. These include blood draws, blood pressure and doppler 
ultrasound. Finally, I have been working with a variety of participants at the Adult Physical 
Fitness Program at Ball State University and Ball Memorial Hospital. These experiences 



























Literature Review  
 
Table 1: Extra-medial thickness, Arterial Stiffness, and Cardiovascular Risk Factors 
Study Purpose Sample Study Design Results 
Cai et al, (2016) 
-Structural changes may be 
associated with arterial stiffening. 
 
-It is hypothesized that children with 
increased EMT would have increased 
arterial stiffness. 
-248, 8-year-old children. 
-Observational. 
 
-Measures of arterial stiffness 
included Beta-stiffness index, 
distensibility index, and incremental 
modules of elasticity.  
-Carotid EMT is correlated with all three 
measures of arterial stiffness (p=0.02, 
p=0.03, p=0.05). 
 
-The results indicate that carotid EMT is 
associated with stiffness and specifically 
the arterial adventitia could be correlated 
with arterial stiffness during childhood. 
Skilton et al, 
(2009) 
-Measurement of carotid EMT with 
ultrasonography. 
 
-The focus of this study was looking at 
vascular health in healthy, and non-
healthy individuals. 
-175 subjects (54 diabetic, 43 
dyslipidemia, 26 other CVD 





-EMT was increased from those who were 
diabetic and with dyslipidemia (p<0.001, 
0.04) compared to the healthy individuals. 
Demonstrating a linear relationship with 
EMT and cardiovascular risk factors. 
Skilton et al, 
(2011) 
-Carotid IMT is a non-invasive marker 
of cardiovascular disease. 
 
-To determine the effect of IMT and 
adventitia with ultrasound on carotid 
wall thickness in heathy individuals. 
-Carotid ultrasound and 
magnetic resonance imaging 




-To see effects of vascular 
measurements on healthy 
individuals. 
-Results included ultrasound-derived 
measures of arterial wall thickness, which 
were highly correlated with wall thickness 
(p<0.001). 
 
-The EMT contributed greater to 
information concerning vascular structures 
than IMT alone. 
Skilton et al, 
(2012) 
- The purpose of this study to was to 
determine associations between EMT 
and CVD risk factors in younger 
children. 
-389, 8-year old children were 
analyzed with high-resolution 




-389 participants were analyzed with 
ultrasound by EMT thickness.  
-EMT was lower in girls and was closely 
correlated with blood pressure. The same 
remained true for IMT. 
 
-Thicker EMT is associated with gender in 
height in younger children. Indicating that 
EMT may give useful information about 
early arterial health.  
 
Skilton et al, 
(2014) 
-The purpose was to determine if fetal 
growth and postnatal growth is 
connected with EMT in children. 
-Ultrasound analysis with 379 




-Carotid EMT was measured with 
ultrasonography  
-Weight gain for birth to 2.5 years was 
associated with EMT. This association 
was higher in boys than girls.  
 
Summary: Based on the literature there appears to be associations between EMT and arterial stiffness across all age groups. This allows for 









Table 2 Part A: Extra-media thickness, and Measures of Arterial Stiffness  
Study Purpose Sample Study Design Results 
Haberka et al, 
(2015) 
-Determining associations between 
EMT thickness, obesity, and metabolic 
syndrome. As well as CV risk factors. 
-Four hundred patients were 
included in the study (age: 





-Both the common carotid arteries 
and EMT/IMT were measured, along 
with body fat, and anthropometric 
measurements. 
-EMT for those with metabolic 
syndrome was found thicker and was 
correlated with fat distribution and 
general obesity (p < 0.001). 
 
-This indicates there is a relationship 
between EMT and metabolic 
syndrome. 
Haberka et al, 
(2015) 
-The goal was to determine associations 
between periarterial fat, EMT and CAD 
in comparison with patients in high and 
very high CVD risk categories. 
Four hundred twenty-two patients 
scheduled for elective coronary 
angiography were included in the 





-EMT and IMT as well as epicardial 
and pericardial fat thickness were 
measured. These participants had 
an estimated cardiovascular risk of 
82% and 60%. 
-For patients with CAD and critical 
coronary stenosis there was higher 
EMT compared to the control groups. 
 
-The combination of ultrasound 
indexes related to periarterial fat and 
vascular wall (PATIMA index) is 
associated with more complex CAD 
in high and very-high risk patients. 
Haberka et al, 
(2015) 
 
-The purpose was to evaluate the 
association between carotid EMT and 
epicardial fat and pericardial fat and 
their association to cardiovascular risk 
and metabolic syndrome. 
 
 
-One hundred consecutive patients 
(age: 51.7 ± 15.4 years; males 
70%) scheduled for cardiac 
magnetic resonance were 
prospectively included in the study. 
-Observational. 
-Higher risk subjects demonstrated 
associations with increased EMT. 
Carotid EMT may be a good 
surrogate marker, of both periarterial 
fat and arterial adventitia. 
Lefferts et al, 
(2017) 
-The purpose was to determine 
associations of Carotid stiffness, EMT, 




-135 healthy males (20 ± 2 years, 




-Observational design. Two 
separate measurements on different 
days included vascular, and 
anthropometric. Brachial and carotid 
systolic, diastolic, and pulsatile 
blood pressure were measured with 
oscillometric cuff and applanation 
tonometry. 
 
-Carotid PP and EMT are correlated 
to Beta-stiffness. Results suggest 
visceral adiposity could change 
markers of CVD and could contribute 
to arterial stiffness. 




Summary: EMT thickness is related to CAD and CVD risk factors. Additionally, research was gathered on Beta-stiffness and ultrasonography to 





















Table 2 Part B:  Extra-media thickness, and Measures of Arterial Stiffness 
Lyle et al, (2017) 
-Overview of some of the most 
common mechanisms that contribute 
to increased arterial stiffness. 
-Various subjects with different 
clinical risk factors. -Review article. 
-Arterial stiffness is accelerated with 
various risk factors. Some of which 
include TD2. Additionally, arterial 
stiffness is a precursor for many 
common risk factors. 
Vriz et al, (2017)  
-To compare arterial 
stiffness/compliance in the aorta and 
common carotid artery and its effect on 
left ventricular structure and function. 
-548 healthy subjects. -Observational. 
-Common carotid artery stiffness 
parameters were correlated with age 
and systolic blood pressure. 
-Common carotid stiffness measures 
were better predictors of left 
ventricular structure and function than 
aortic stiffness. 
Yuan et al, (2016)  
-The purpose was to determine the 
predictive value of carotid distensibility 
coefficient for cardiovascular diseases 
and all-cause mortality. 
 
-20,361 subjects over 11 
longitudinal studies. -Meta-analysis. 
-Carotid distensibility coefficient 
predicted future cardiovascular 
events and all cause-mortality. 
-This may help diagnosis of high-risk 
















Table 3: Arterial Stiffness and Mortality  
Study Purpose Sample Study Design Results 
Greenwood et al, (2019) 
-PWV noninvasive tool to 
measure stiffness. PWV is 
hypothesized to predict kidney 
injury. 
37 patients were included in the 
study. 85% were male, and mean 






-1.5 greater chance of kidney injury with 
higher PWV. 
 
-Independently predicts acute kidney 
injury. 
Mattace-Raso et al, (2006) 
-Determining if arterial stiffness is 
a risk for coronary artery disease 
and stroke in healthy subjects. 
 
-The present study included 2835 
subjects participating in the third 





follow-up of 4.1 years. 
 
- “Arterial stiffness was 
measured as aortic pulse 
wave velocity and carotid 
distensibility.” 
 
-CAD risk was found to be greater in 
those with higher PWV. 
 
-Aortic PWV was found to be an 
independent risk factor for stroke and 
CAD in healthy adults. 
 
















Table 4: Arterial stiffness, Pressure Components and Associations for CVD risk 
Study Purpose Sample Study Design Results 
Bortel et al, (2002) 
-Information about arterial 
stiffness and pressure 
components and its clinical 
applications. 
-n/a -n/a 
-Arterial stiffness is related to distensibility 
and compliance, explained through these 
equations: 
Carotid Compliance: πDmin*ΔD/2*ΔP and 
 
Carotid Distensibility: 2*[(ΔD/Dmin/ΔP] 
 
Gaddum et al, (2015) 
-A novel technique is used to 
modulate intrathoracic 
pressure and aortic 
transmural pressure in 
normotensive and 
hypertensive individuals. 
-n=20; age, 52.1±15.3 years 
(hypertensive) 




-Doppler probes, and PWV. 
 
 
-PWV velocity was higher in hypertensive 
individuals. 
-Hypertension is related to elastin and 
wall/diameter changes. 
 
Lehman et al, (2010) 
-Perivascular fat may play a 
role in obesity mediated 
vascular disease. 
 
-(n=1067, mean age 59 years, 
56.1% women), thoracic peri-aortic 
fat depots were quantified. Visceral 
abdominal tissue and calcification of 
the thoracic and abdominal aorta 
were also measured. 
 
-Observational. 
-Thoracic peri-aortic fat is associated with 
measures of adiposity, metabolic risk 
factors, and coronary and abdominal 
aortic calcification. 
 
Mitchell et al, (2010) 
To determine cardiovascular 
risk makers in relation to 
PWV. 
-2232 total participants all part of 
the Framingham Heart Study. 
-Observational, with a mean follow 
up of 0.2-8.9 years. 
-Results demonstrated that 6.8% had an 
event (151/2232) and higher aortic PWV 
was associated with 48% increase risk of 
CVD. 
 











Table 5: EMT Stucture Breakdown (peivascular adipose tissue, arterial adventitia, and interstitial wall) 
Study Purpose Sample Study Design Results 
Fleenor et al, (2010) 
-They tested the hypothesis that 
carotid artery stiffening with aging is 
associated with changes in vascular 
structures and could be reversed 
with aerobic exercise. 
-Twenty young (4–7 months) 
and 20 old (29–32 months) 
male B6D2F1 mice 
-Experimental. 
 
-Increases in carotid artery stiffness with aging are 
associated with TGF-B1 stimulated increase in 
adventitial collagen I and III related to changes in 
fibroblasts. With aerobic training many of these 
changes can be delayed or reduced. 
 
Schulze-Bauer et al, (2002) 
-Inflation tests of 11 non-stenotic 
human femoral arteries were 
performed during autopsy. 
 
-Eleven human femoral 
arteries (79.3±8.2 years, 
means ± SD) were 




-Those arteries that were stiffer were not as 
efficient at dilation and constriction as well as 
those who had excess pressure were more 
susceptible to hardening. 
Sommer et al, (2010) 
-To enhance the knowledge of the 
mechanical functions of arteries and 
their associated layers in specific 
pathophysiological and clinical 
problems, such as hypertension and 
angioplasty with stenting. 
 
-Eleven human CCAs and 
10 human ICAs were 
harvested from 11 human 
subjects ranging from 67 to 





-Negative correlations were found with age and 
axial inversion stretches for the CCA’s. Due to 
aging being related to a decrease in distensibility, 
structural changes and loss of elastin fibers. 
Sousa et al, (2019) 
-The present study aimed to 
investigate the effects of aerobic 
exercise training on PVAT-induced 
endothelial dysfunction of thoracic 
aorta of obese mice. 
 
-Male sedentary and obese 
rats. -Observational. 
-The PVAT-induced endothelial dysfunction in 
obese rats was associated with circulatory 
inflammation and oxidative stress. Aerobic 
exercise training upregulated the antioxidant 
expression and decreased PVAT oxidative stress 
with a beneficial impact on endothelium-
dependent relaxation. 
 













Table 6: Coconut-Derived Substances and Beet Juice on Cardiovascular Risk 
Study Purpose Population Study Design Results 
Asgary et al, (2016)  
To investigate the effect of raw 
beet juice and cooked beet juice 
on blood pressure in hypertensive 
subjects. 
-24 hypertensive subjects 
(25-68 years old). 
 
-Randomized crossover. 
-Overall, both forms of beet root juice 
improved blood pressure, endothelial 
function, and systemic inflammation, 
however, the raw beet juice had greater 
anti-hypertensive effects. 
Jose et al, (2017) 
-To see the effect of a coconut 
derived supplement on 
inflammatory makers (such as 
kidney function) in rats. Which is 
hypothesized to have great health 
benefits. 
-Adult male Wistar rats. 
 
-Experimental randomized control. 
 
-The animals were grouped into three 
groups one with vehicle, one with 
gentamicin and one with gentamicin 
+CSP for 16 days. 
-Coconut flower sap has a great potential 
to prevent or reverse kidney damage. 
 
-CSP, demonstrated many anti-
inflammatory markers of kidney function 
contributing to the hypothesis of CSP to 
have great anti-inflammatory health 
benefits. 
Lima et al, (2015) 
-To review the effect Cocos 
nucifera has on phytochemical, 
pharmacological and toxicological 
aspects in humans and to guide 
future clinical research. 
-n/a -Review article  
-Cocos nucifera demonstrated positive 
effects on vascular health but varies 
depending on the part of the plant 
studied.  
Ratheesh et al, (2017) 
-To determine the ant-
inflammatory effects of a coconut-
derived substance on LDL and 
atherosclerosis. 
-Healthy human volunteers 
in three different groups. 
-Experimental Design. 
 
-Human peripheral blood mononuclear 
cells were isolated between cultured 
groups (1,2,3) and analyzed for 
inflammatory markers. 
-The use of the coconut substance 
helped decrease inflammatory effects on 
human peripheral blood mononuclear 
cells. 
 
Summary: Anti-inflammatory substances can reduce inflammation and functional measures of the vasculature. 
 
Abbreviations: EMT, extra-medial thickness, IMT, intima-medial thickness, CVD, cardiovascular disease, CAD, coronary artery disease, %, percent, PATIMA, 
periarterial index, BMI, body mass index, kg, kilograms, m, meters, PP, pulse pressure, D, diameter, Δ, change, P, pressure, min, minimum, max, maximum, 
TD2, type-2 diabetes, PWV, pulse wave velocity, SD, standard deviation, PVAT, perivascular adipose tissue, CCA, common carotid artery, ICA, internal carotid 
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